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Internal Medicine Consultation
for Dentists

Nina Mingioni, MD FACP
Internal Medicine
Sidney Kimmel Medical College
Thomas Jefferson University

Gerteis J, Izrael D, Deitz D, LeRoy L, Ricciardi R, Miller T, Basu J. Multiple Chronic Conditions Chartbook. AHRQ
Publications No, Q14-0038. Rockville, MD: Agency for Healthcare Research and Quality. April 2014.

Learning Objectives
Recognize ubiquitous nature of common medical condition in
general population

Discuss implications of common medical conditions on dental care
of patients

Identify concerns affecting patients that would necessitate medical
consultation prior to dental intervention
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Hypertension

CHRONICALLY ELEVATED BLOOD
PRESSURE >140/90

29% OF ADULTS IN US
(1 IN 3!!!!!)

ONLY 54% CONTROLLED

Elevated Blood Pressure in the office
Previously undiagnosed hypertension

Known hypertension

White coat hypertension

Pain

Chronically uncontrolled
Usually controlled, but uncontrolled today

What is “dangerously elevated blood pressure?”
Hypertensive Urgency
• SBP >180 and/or DBP >110
• Asymptomatic
• ?mild headache

Hypertensive Emergency
• SBP >180 and/or DBP >110
• Altered Mental Status
• Stroke (ischemic/hemorrhagic)
• Acute coronary syndrome
• Hearth failure
• Renal failure

When to send to ER?
• SBP >180 and/or DBP >110
• Altered Mental Status
• Stroke (ischemic/hemorrhagic)
• Retinopathy
• Acute coronary syndrome
• Aortic dissection
• Hearth failure
• Renal failure

Lethargy/confusion
Neurologic deficits
Blurry vision
Chest pain
Shortness of breath
Blood in urine

What to ask your patient…
Do you have…. (ask for “red flag symptoms”)
Have you ever been told you have elevated blood pressure?
Did you take your medications today?
Do you check your blood pressure at home?
What was your blood pressure last time you went to see your doctor?

White Coat Hypertension
Blood pressure is consistently elevated by the office readings but does not meet diagnostic criteria
for hypertension based on out-of-office readings

15-30% of all patients with elevated office readings

Diagnosis

In-office interval readings

Ambulatory blood pressure monitoring

So, your patient has elevated BP…
• >180/110 – ask for “red flag symptoms”

• Present – send to ER
• Absent – send to their primary care physician
• Dental treatment should (probably) not be performed that day
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Hypoglycemia
VS
Hyperglycemia

Who gets hypoglycemia?

PATIENTS ON INSULIN

PATIENTS TAKING
SULFONYLUREA MEDICATIONS

Medications that do NOT cause hypoglycemia

Metformin

TZDs

DPP4
inhibitors

GLP-1
analogues

SGLT-2
antagonists

Pre-procedure advice:
Patients on insulin
• Long acting insulins: glargine (Lantus/Basaglar), detemir (Levimir),
diglutec (Tresiba)
continue full dose without adjustments
• Patients with insulin pumps
continue full dose without adjustments

Pre-procedure advice:
Patients on insulin
• Pre-mixed insulin: 70/30, 75/25, 50/50
HALF of usual morning dose
• Intermediate acting insulin: NHP
HALF of usual morning dose
• Short acting insulins: lispro, aspart, glulisine
NONE, unless patient is eating

What if patient is hypoglycemic?
• Glucose tablets
• Glucose gel
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Anticoagulants
Antiplatelet medications (aspirin, clopidogrel, prasugrel)

Vitamin K antagonists (warfarin)

Heparins (UFH, LMWH)

Novel oral anticoagulants

Factor Xa inhibitors: apixaban, rivaroxaban
Direct thrombin inhibitors: dabigatran

Anticoagulants: indications
• Treatment of acute event
• Primary prophylaxis

• Aspirin for heart disease, stroke prevention
• Warfarin/NOACs for stroke prophylaxis in Atrial Fibrillation
• Warfarin for stroke prophylaxis in patients after valve replacement

• Secondary prophylaxis
• Heart disease
• Strokes
• Clots

Interruption?

MOST PATIENTS ->

HIGH BLEEDING RISK ->

CONTINUE MEDS

TALK TO THE PRIMARY CARE DOC

Coagulopathy due to other medical conditions
Bone marrow disorders
Chronic kidney disease
• Dialysis patients

Hereditary
coagulopathies

Chronic liver disease

Autoimmune
(idiopathic
thrombocytopenic
purpura)

• Myelodysplasia
• Hematologic malignancies
• Recent chemotherapy

Advanced heart failure
(with secondary liver
dysfunction)
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Would you consider antibiotic to prevent
infections in patients with…
Prosthetic valve?

Prosthetic joint?

Breast implants?

Immunosuppressed?

Pacemaker?

Coronary stent?

Dialysis AV graft?

Endocarditis Prophylaxis: YES
Prosthetic valves

History of
endocarditis

Congenital heart
disease

Hearth transplant
recipients with
valvulopathy

Unrepaired
cyanotic heart
disease

Cyanotic heart
disease with repair
that used
prosthetic material
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Antibiotic prophylaxis: how effective is it?
• No human study has definitively demonstrated that prophylactic
antibiotics prevent endocarditis after invasive procedures
• Risk factors appear to be presence of structural heart defect, NOT the
dental procedure
• Epidemiologic studies: less than 10% of IE is prevented by antibiotic
prophylaxis
• Less than 5% of IE are actually preceded by a dental procedure (not a
proof of causation)
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Antibiotics: what’s the big deal?
development of antibiotic-resistant bacterial pathogens

C. difficile infections

Severe allergic reactions

Costs

malpractice litigation
additional medical and dental office visits

Who does

NOT

need
antibiotic
prophylaxis…

• Patients with pacemakers/defibrillators
• Patients with vascular grafts, including dialysis
grafts
• Patients with endovascular grafts
• Patients with coronary stents
• Patients with Vena Cava filters
• Patients with VP shunts
• Patients with breast implants
• Patients with prosthetic joints
• Pregnant patients

May need antibiotic prophylaxis…
• Immunocompromised patients?
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Immunocompromised: what’s the big deal?

High risk of infection
Depends on degree of immunosuppression

High risk of malignancy

Immunocompromised populations

DISORDERS OF
BIOCHEMICAL
HOMEOSTASIS

DISORDERS OF PROTEIN
LOSS

IMMUNOSUPPRESSIVE
THERAPY

VIRAL INFECTIONS (HIV)

MALIGNANCY

ASPLENIA/HYPOSPLENISM

AUTOIMMUNE DISEASES
(LUPUS, RHEUMATOID
ARTHRITIS)

Disorders of biochemical homeostasis

DIABETES

CHRONIC KIDNEY
DISEASE/UREMIA

CIRRHOSIS

MALNUTRITION

Disorders of protein loss

NEPHROTIC SYNDROME

PROTEIN-LOSING
ENTEROPATHIES

Immunosuppressive therapy
Cytotoxic chemotherapy for malignancy

Autoimmune disease treatment

Treatment of rejection after solid organ transplantation

Treatment/prophylaxis of graft-vs-host disease after bone marrow transplant

Malignancy

Hodgkin
disease

Chronic
lymphocytic
leukemia

Multiple
myeloma

Solid tumors

Immunocompromised populations

AUTOIMMUNE DISEASES (LUPUS,
RHEUMATOID ARTHRITIS)

VIRAL INFECTIONS (HIV)

ASPLENIA/HYPOSPLENISM

Immunocompromised
• Do they need antibiotics before dental procedures?
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Bisphosphonates: indications
Osteoporosis
Sometimes: Osteopenia
Patients on chronic corticosteroids
Paget’s disease
Cancer patients with bone metastases

IV vs PO therapy: risks differ
Zolendronic acid vs placebo: 50100x risk of osteonecrosis

Oral bisphosphonate therapy

1% (1 case per 100)

Short term: 0.1% (1 cases per 1000)
>4 years: 0.21% (1 cases per 500)

Difference is the dose:
Zolendronic acid dose is 10x higher than doses of PO bisphosphonates

Drug holiday? No Data!
Recommendations:
• ADA (2011): if on meds <2 years, continue during invasive dental treatment
• ONJ Task force (2013): drug holiday if >4 years on meds or risk factors (RA,
long term steroids, DM, smoking)
• AAOMS (2014)
• Optimize dental health before IV bisphosphonates
• PO bisphosphonates <4 years and no risk factors: no holiday
• PO bisphosphonates <4years but with risk factors: 2mo holiday before, restart once
bone heals
• PO bisphosphonates >4years: 2mo holiday before, restart once bone heals

• AACE (2016): delay initiation until dental issues are corrected. No evidence
for drug holiday, but consider.

Bisphosphonate Drug Holiday: Summary
No Data

On meds >4 years

Consider drug
holiday if:

Risk factors for
osteonecrosis

How long???

All patients on
bisphosphonates?

Summary
Incidence of chronic illness increases with age
Many of your patients will have special considerations in their dental care
Know how to properly check a blood pressure, and when to send to ER
Have a source of glucose in your office
Most patients do not need anticoagulation interruption
Most patients do not need prophylactic antibiotics
Incidence of osteonecrosis in patients with PO bisphosphonates is low
When in doubt, call their primary care doctor (and have low threshold to do so)

Questions?

